NOTE: Swing! is mentioned in
this article under "The New Broadway,"
but the entire article should be of interest to theatregoers.
Old fashion Although plays essentially have abdicated from Broadway, there is always room for an old chestnut -- and it doesn't hurt if there's a star attached. "The Rainmaker," reviewed in the P-I on Nov. 22, continues to sell well with Woody Harrelson atop the marquee. The limited-run romance, which closes Feb. 6, has as fine an acting ensemble as the recently departed (and celebrated) production of Arthur Miller's "Death of a Salesman." Film star Harrelson seems a bit out of his depth, but ultimately holds his own. "Salesman" was scarcely out of the theater district when Miller's "The Price" opened. Revolving around the settlement of a parent's estate, the 1968 play features two brothers (Jeffrey DeMunn and Harris Yulin) who dredge up the past and then muck about in familial recriminations. It's as if Biff and Hap, the brothers in "Salesman," have grown up and returned home to face the truth about their lives and one another. Bob Dishy plays an ancient, philosophical junk dealer who provides much of the play's considerable humor. But DeMunn and Yulin never relent in their middle-age search for answers, and we are content to probe along with them. The big non-musical hit so far this season actually has a bit of song and dance in it. "Dame Edna: The Royal Tour" is an achingly funny trip through the addled head of "Edna Everage," the alter ego of theater artist Barry Humphries. Dame Edna, who treats her audience as if we are her beloved subjects, takes cutting aim ("but only in the most lovely way, possums") at class, sexuality and fashion. Talking directly to the audience, she invites a couple to dine onstage (they do), makes a phone call to check on a baby sitter in Ohio and provides makeovers to the fashion-challenged. "Dame Edna" is unquestionably the funniest show on Broadway.
Seattle connection As always, Seattle connections abound in New York theater. This season, though, there have been two big disappointments. "Scent of the Roses," which began life under the guidance of Gordon Edelstein at A Contemporary Theatre, was slated to open on Broadway in December. Due to apparent financing difficulties, the production has been put on hold. "Voices in the Dark," which premiered at ACT when the company was still in its old Queen Anne home, got the season rolling back in August. Judith Ivey played the role of a radio psychologist with relationship problems and a menacing stalker. Although there once was a place for thrillers on Broadway, they just don't draw audiences these days. "Voices" fell silent after 12 previews and 68 performances. There's good news on the horizon, though, as director Dan Sullivan -- formerly of the Seattle Rep -- prepares a production of Eugene O'Neill's "Moon for the Misbegotten." Starring the superb Cherry Jones and film actor Gabriel Byrne, the production will bow at Chicago's Goodman Theatre in January before heading to New York. Sullivan has been on a roll as a New York stage director since departing the Rep. In 1998, he directed a sublime production of O'Neill's gentle comedy "Ah, Wilderness!" at Lincoln Center. Earlier this season, he staged a fine off-Broadway production of Donald Margulies' "Dinner with Friends." A must-see for any theater lover, the Margulies play is still running strongly at the Variety Arts Theatre.
Holiday Crush The Broadway season got an early, but slow, start this year. As the holiday season reaches its peak, openings abound. Between now and New Year's, there's a dark musical based on the Medea myth ("Marie Christine"), a daughter celebrating her father and his art ("Minnelli on Minnelli"), a dark comedy about art and artists ("Wrong Mountain"), a play revival ("Amadeus"), an American premiere (Noel Coward's "Waiting in the Wings") and another solo comedy ("Jackie Mason: Much Ado About Everything"). The new year will bring Disney's troubled Elton John/Tim Rice musical spectacle, "Aida," to Broadway. Cameron Mackintosh's latest musical, "Martin Guerre," which has had its own difficulties, will bow in the spring. It remains to be seen whether critics are now irrelevant as some theater folk claim. However, it is a very good thing that a rotten review from The New York Times cannot automatically kill a show, as it once could. When the business cycle turns, consumers may not be quite as flush with disposable income as they are now. At that point, we will all be a bit more careful about how we spend our money. Where, then, will a family of four turn when deciding which show gets their $300 for orchestra seats? Hopefully, right here.